Medical Rationale
Hypothyroidism promotes obstructive sleep apnea through multiple mechanisms. First, hypothyroidism lowers the basal metabolic rate by 15 to 30 percent, reduces thermogenesis and causes fluid retention, so body weight rises. The added weight increases pharyngeal fat deposition and tongue base volume, narrowing the upper airway. Second, hypothyroidism directly reduces upper airway dilator muscle (genioglossus) tone by impairing neuromuscular function, increasing airway collapsibility during sleep. Third, myxedema, the accumulation of glycosaminoglycans in pharyngeal soft tissues, causes mucosal edema that further compromises airway patency. Studies demonstrate a 25-35% prevalence of OSA in hypothyroid patients compared to 5-10% in the general population.
Key Studies
Attal P & Chanson P (2010) Eur J Endocrinol (endocrine aspects of obstructive sleep apnea); Resta O et al. (2004) J Endocrinol Invest (hypothyroidism and obstructive sleep apnea, prevalence study).
Filing Tips
Polysomnography (sleep study) documenting OSA with AHI score. Document weight gain trajectory temporally correlated with hypothyroidism onset. BMI and neck circumference measurements. Endocrinology or pulmonology/sleep medicine nexus letter addressing the dual mechanism (weight gain and pharyngeal myxedema). If hypothyroidism treatment partially improves OSA, this actually strengthens the causal link. File under DC 6847 (sleep apnea syndromes).
